Screening Program May Help to Maximize Colorectal Cancer Screening Rates

Share this content:
A screening program may be able to successfully maximize colorectal cancer screening rates.
A screening program may be able to successfully maximize colorectal cancer screening rates.

A screening program may be able to successfully maximize colorectal cancer (CRC) screening rates, according to a recent study published online ahead of print in Cancer.1

Steven Itzkowitz, MD, of the Icahn School of Medicine at Mount Sinai in New York, NY, and fellow researchers formed a coalition among stakeholders of the New York City Department of Health and Mental Hygiene in 2003 with a primary focus on colonoscopy in order to increase screening rates and ensure equal access with respect to race/ethnicity.

They found that the program was able to increase colonoscopy rates from 42% in 2003 to 62% in 2007, then 70% in 2014 after eliminating racial and ethnic disparities.

RELATED: Low BMI Linked With Progression, Death Risk in Colorectal Cancer

“The authors hope that by sharing the many elements involved and the lessons learned, they may help other communities to adapt these experiences to their own environments so that CRC screening rates can be maximized,” they noted.

Reference

  1. Itzkowitz SH, WInawer SJ, Krauskopf M, et al. New York Citywide Colon Cancer Control Coalition: a public health effort to increase colon cancer screening and address health disparities [published online ahead of print November 23, 2015]. Cancer. doi: 10.1002/cncr.29595.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs